COYA
Coya Therapeutics, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$111.19M
P/E Ratio
—
EPS
$-1.15
Beta
0.62
52W High
$7.75
52W Low
$3.71
50-Day MA
$4.50
200-Day MA
$5.23
Dividend Yield
—
Profit Margin
-266.10%
Forward P/E
—
PEG Ratio
—
About Coya Therapeutics, Inc. Common Stock
Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary medicinal products to modulate the function of regulatory T cells (Tregs). The company is headquartered in Houston, Texas.
Fundamentals
| Revenue (TTM) | $7.94M |
| Gross Profit (TTM) | $-7.68M |
| EBITDA | $-20.20M |
| Operating Margin | -3038.00% |
| Return on Equity | -51.30% |
| Return on Assets | -27.60% |
| Revenue/Share (TTM) | $0.44 |
| Book Value | $2.09 |
| Price-to-Book | 2.23 |
| Price-to-Sales (TTM) | 14.01 |
| EV/Revenue | 7.35 |
| EV/EBITDA | -6.21 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -2.60% |
| Shares Outstanding | $23.46M |
| Float | $17.54M |
| % Insiders | 14.69% |
| % Institutions | 35.37% |
Historical Volatility
HV 10-Day
71.36%
HV 20-Day
62.78%
HV 30-Day
70.31%
HV 60-Day
68.97%
HV Rank
78.2%
Volatility is currently expanding
Analyst Ratings
Consensus ($15.21 target)
5
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026